Andrew Kiguel
CEO | Realbotix Corp | Humanoid Robotics and AI Executive
"Leading Realbotix's humanoid robotics commercialization and Nasdaq listing strategy"
Biography
Andrew Kiguel is the Chief Executive Officer of Realbotix Corp (TSX-V: XBOT | OTC: XBOTF | FSE: 76M0.F), a company that designs and manufactures humanoid robots with embedded artificial intelligence. He leads the company through a transitional phase as it scales production and pursues a Nasdaq listing via a reverse takeover of Onconetix, Inc. His background includes navigating capital markets for emerging technology companies on Canadian exchanges.
Under Kiguel's leadership, Realbotix has reported growing interest from healthcare and education sectors, with orders for real-world deployments. The company posted approximately $442,000 in income for a recent quarter and is working to scale manufacturing capacity to meet anticipated demand. Kiguel has been transparent about the timing gap between execution and revenue recognition, noting that reported revenue lags operational progress due to delivery schedules.
Kiguel's strategy centers on addressing what he describes as the interface challenge between AI and the physical world — moving artificial intelligence from screen-based applications to physical presence through humanoid robots. Realbotix's products include modular, lifelike humanoid robots designed for human interaction. The company has pursued visibility through investor conferences and media appearances to build awareness following its July rebrand to Realbotix.
It should be noted that Andrew Kiguel and Realbotix operate in the humanoid robotics and AI technology sector, not in commodities, mining, or natural resources. Resource investors encountering his media appearances should understand that his expertise lies in emerging technology commercialization rather than mineral exploration, commodity markets, or mining investment.
Videos (2)
Realbotix ($XBOT | $XBOTF) CEO Discusses AI Humanoid Robots and Commercial Growth
- Top takeaway Expects the subsidiary's NASDAQ listing via the OnContax transaction to close in the second half of 2026, arguing it could make Realbotix the first pure-play robotics company on the NASDAQ and attract ETF and specialty-fund attention, with a goal of having a robot open the market this fall.
- Argues most robotics investment is chasing industrial labor robots while the larger opportunity is the service sector — about 70% of the workforce is non-physical — which he calls a trillion-dollar opportunity for social robots.
- Points to new eldercare and education deals as commercial traction: an agreement with Bloom Services in the UK to pilot robots in retirement homes, and a first-of-its-kind deployment with the Salamanca School District in Upstate New York, with plans to reach about 500 high school students this fall.
- Claims Realbotix trades at about a $50 million valuation as of the July 2026 interview — a large discount to other robot companies in his view — and says he believes it can become a billion-dollar company.
- Describes a multi-stream revenue model of $12,000-$150,000 robots plus monthly AI fees, hardware sales and maintenance plans, with a lower-priced 'Echo' robot line expected within weeks of the interview.
Realbotix Investor Webinar: Commercial Traction, Nasdaq Path, and What Comes Next | April 23, 2026
- Top takeaway Kiguel says the company's top near-term milestone is completing the announced NASDAQ transaction, which he argues brings capital and a US listing without dilution while XBOT holders keep primary ownership — potentially the first pure-play humanoid robotics company on NASDAQ.
- He argues Realbotix is not competing with Tesla or Figure AI: their walking robots run about 30 minutes per charge, while his wheeled, wall-pluggable robots last around 10 hours and can safely serve public-facing roles in hotels, schools, and senior care.
- He points to Ericsson as early commercial traction: a CES rental programmed as a 6G expert for the Verizon head office turned into robot orders and, as of the webinar, delivery of the first Vinci vision robot.
- He says production should reach the hundreds of robots by the end of 2026 and thousands by the end of 2027, from a new US office that was under construction at the time of the webinar.
- He sees healthcare and education as the key next markets — companionship for lonely or elderly people, clinical-trial monitoring that he says removes human bias, and AI tutoring at a couple of dollars a month — with the vision-enabled Ask Aria app relaunching in May as a free trial before a paid tier.
Key Quotes
"We are excited about the momentum we're building at Realbotix including an uptick in interest from the healthcare and education verticals."
— Q2 2026 financial results announcement
"Realbotix is solving one of the most important challenges in AI adoption: the interface between AI and the real world."
— Robot delivery update press release
Key Works
Quarterly results showing revenue figures and forward strategy for robotics deployments
Specializations
Disclaimer: Andrew Kiguel has NOT endorsed this platform and is not affiliated with Pixys in any way.